Top brokers name 3 ASX shares to sell today

Medibank Private Ltd (ASX:MPL) shares are one of three that top brokers have named as sells this week…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

On Wednesday I looked at three ASX shares that brokers have given buy ratings to this week. Unfortunately, not all shares are in favour with them right now.

Three that have just been given sell ratings are listed below. Here's why these brokers are bearish on them:

Cochlear Limited (ASX: COH)

According to a note out of Credit Suisse, its analysts have retained their underperform rating and $168.00 price target on this hearings solutions company's shares following a recent update from its rival. Switzerland-based Sonova reported a 4.8% lift in sales and a 16% increase in net profit during its second half. In light of this and its view that Cochlear's new implant will have little benefit until it is available in all developed markets, its analysts suspect that the company could lose market share to its rivals, putting it at risk of falling short of its guidance. The Cochlear share price is currently up 1.5% to $202.09.

Medibank Private Ltd (ASX: MPL)

A note out of Goldman Sachs reveals that its analysts have retained their sell rating and $2.50 price target on this private health insurer's shares following the release of APRA's private health insurance industry data for the March quarter. According to the note, that data revealed that policyholder growth remains negative with further youth exits. Furthermore, the broker believes that the data shows that industry revenue trends are deteriorating and expects further gross margin deterioration to occur. Medibank's shares are up 1.5% to $3.24 today.

Sonic Healthcare Limited (ASX: SHL)

Analysts at UBS have downgraded this healthcare provider's shares to a sell rating with an improved price target of $24.90. According to the note, the broker notes that the company is experiencing increasing costs and declining organic revenue growth in several markets. But the main reason for the downgrade is its valuation. UBS believes the market has ascribed a larger than deserved multiple to the company's Australian pathology. The Sonic Healthcare share price is down over 1% to $26.14 this afternoon.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. The Motley Fool Australia has recommended Cochlear Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Broker written in white with a man drawing a yellow underline.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Man holding Australian dollar notes, symbolising dividends.
Dividend Investing

Want to build up passive income? These 2 ASX dividend shares are a buy!

These stocks are giving investors exciting payouts every year.

Read more »

Man on a ladder drawing an increasing line on a chalk board symbolising a rising share price.
Growth Shares

2 ASX shares to buy and hold for the next decade

These businesses have a lot of growth potential ahead…

Read more »

Three satisfied miners with their arms crossed looking at the camera proudly
Materials Shares

ASX 200 materials sector outperforms as mining shares continue their ascent

Plenty of ASX 200 mining shares hit multi-year highs last week amid continually rising commodity values.

Read more »

A group of people push and shove through the doors of a store, trying to beat the crowd.
Broker Notes

2 ASX shares highly recommended to buy: Experts

Are these two stocks the best buys on the ASX?

Read more »

Smiling couple sitting on a couch with laptops fist pump each other.
Broker Notes

These ASX 200 shares could rise 20% to 55%

Brokers have good things to say about these shares.

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Dividend Investing

I'd buy 5,883 shares of this ASX stock to aim for $1,000 of annual passive income

I’d pick this stock for its strong dividend record.

Read more »

A player pounces on the ball in the scoring zone of the field.
Best Shares

4 ASX 300 shares that ripped 100% or more in 2025

The S&P/ASX 300 Index rose 7.17% and delivered a total return, including dividends, of 10.66% in 2025.

Read more »